(34 days)
Not Found
No
The device description and intended use are for a simple fluid delivery set, and there is no mention of AI, ML, or any related technologies.
No.
Explanation: The device is an extension set for fluid delivery, not a device that provides therapy itself. It facilitates the delivery of therapeutic fluids but is not inherently therapeutic.
No
The device description states its purpose is "for the delivery of fluids from a container to a patient's vascular system," which is a treatment function, not a diagnostic one.
No
The device description clearly outlines physical components like tubing, adapters, and filters, indicating it is a hardware device, not software-only.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is "for the delivery of fluids from a container to a patient's vascular system." This describes a device used for administering substances directly to a patient, not for testing samples in vitro (outside the body).
- Device Description: The description details tubing, adapters, and connectors, all components consistent with a device for fluid delivery, not for performing diagnostic tests on biological samples.
- Lack of IVD Indicators: There is no mention of analyzing biological samples, detecting analytes, or providing diagnostic information based on testing.
IVD devices are specifically designed to examine specimens derived from the human body (like blood, urine, tissue) to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. This device's function is purely for fluid delivery.
N/A
Intended Use / Indications for Use
The LifeShield® Latex-Free Microbore Extension Set is intended for the delivery of fluids from a container to a patient's vascular system.
Product codes
FPK, FPA
Device Description
The LifeShield® Latex-Free Microbore Extension Set consists of DEHP-plasticized polyvinyl tubing with a secure lock male adapter and air filter assembly on one end and locking female Luer adapter with removable CLAVE® Connector on the other end.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
patient's vascular system
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
LifeShield® Latex-Free Microbore Extension Set Special 510(k) / September 2005
NOV - 2 2005
Special 510(k) Summary
Name of Submitter:
Hospira, Incorporated 275 North Field Drive Lake Forest, Illinois 60045 Owner/Operator #: 9063339
Manufacturer and Establishment Registration Number:
| Manufacturer: | Sterilization Site: |
|---|---|
| Hospira Holdings De Costa Rica, LTD | |
| Zona Franca Global | |
| La Aurora De Heredia, Costa Rica | Hospira, Inc. - Rocky Mount |
| Hwy. 301 North | |
| P.O. Box 2226 | |
| Rocky Mount, NC 27801 | |
| Establishment Registration #: 9615050 | Establishment Registration #: 1021343 |
Proprietary or Trade Name of Proposed Device: LifeShield® Latex-Free Microbore Extension Set Common Name: Fluid Delivery Tubing
Device Classification, Pancode and ProCode: Class II, 80-FPK
Performance Standards: No performance standards have been established under Section 514 of the Food, Drug and Cosmetic Act for Fluid Delivery Tubing. Fluid Delivery Tubing is regulated within 21 CFR 880.5440.
Intended Use Indications for Use:
The LifeShield® Latex-Free Microbore Extension Set is intended for the delivery of fluids from a container to a patient's vascular system.
Proposed Device Description:
The LifeShield® Latex-Free Microbore Extension Set consists of DEHP-plasticized polyvinyl tubing with a secure lock male adapter and air filter assembly on one end and locking female Luer adapter with removable CLAVE® Connector on the other end.
Summary of Substantial Equivalence
The LifeShield® Latex-Free Microbore Extension Set as described in this submission utilizes components (i.e., set tubing and High Pressure CLAVE) from the predicate LifeShield® Latex-Free, Primary IV Pump Set with Distal Microbore Patient Line (K033576) and is substantially equivalent to the predicate LifeShield® Microbore Extension Set (K912103) with respect to the following characteristics:
Similarities:
-
- The extension sets are intended for the delivery of fluids from a container to a patient's vascular system.
-
- The devices are provided with a non-pyrogenic, sterile fluid-path and are intended for one-time use.
-
- The technology and operating principles (i.e., administration/infusion of intravenous medications to a patient's vascular system with the assistance of gravity or an infusion pump are the same, and
-
- The materials of construction are the same.
Differences:
-
- The inner and outer diameter of the set tubing for the modified LifeShield® Latex-Free Microboxe Extension Set is larger and the maximum infusion pressure for the set is specified on the package label.
1
Statement of Safety and Effectiveness
The LifeShield® Latex-Free Microbore Extension Set meets the finances of the states the described in the product labeling, and is as safe and effective in terms of substantial equivalence as the predicate LifeShield® Extension Sets.
2
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features the department's name in a circular arrangement around a stylized caduceus symbol. The caduceus is represented by a series of three curved lines that resemble a human profile. The text reads "DEPARTMENT OF HEALTH AND HUMAN SERVICES . USA".
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Thomas Kozma, Ph.D. Associate Director, Global Device Regulatory Affairs Hospira, Incorporated Department 0389, Building H2 275 North Field Drive Lake Forest, Illinois 60045
Re: K052722
Trade/Device Name: Lifeshield Latex-free Microbore Extension Set, Model 14949 Regulation Number: 880.5440 Regulation Name: Intravascular administration set Regulatory Class: II Product Code: FPA, FPK Dated: September 28, 2005 Received: September 29, 2005
NOV - 2 2005
Dear Dr. Kozma:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act and the limitations described below. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
The Office of Device Evaluation has determined that there is a reasonable likelihood that this device will be used for an intended use not identified in the proposed labeling and that such use could cause harm. Therefore, in accordance with Section 513(i)(1)(E) of the Act. the following limitation must appear in the Warnings section of the device's labeling:
The safety and effectiveness of this device for use with power injection and high power infusion systems have not been established.
3
Page 2 - Dr. Kozma
Please note that the above labeling limitations are required by Section 513(i)(1)(E) of the Act. Therefore, a new 510(k) is required before these limitations are modified in any way or removed from the device's labeling.
The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and permits your device to proceed to the market. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification if the limitation statement described above is added to your labeling.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA). it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific information about the application of other labeling requirements to your device (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0343. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International, and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Hlman, Ph.D., M.P.A. onna-B Director Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known) Ko52722
LifeShield® Latex-Free Microbore Extension Set Device Name:
Indications for Use:
The LifeShield® Latex-Free Microbore Extension Set is intended for the delivery of fluids from a container to a patient's vascular system.
Prescription Use _ X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (Part 21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Dianne Vontz
(Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices
Page 1 of 1
510(k) Number: _